TVTX
Travere Therapeutics, Inc.Company with tickers: TVTX
CIK
1438533
CUSIP
89422G107
Shares Outstanding
92,992,905
13F Activity (30d)
200 filings
175 filers
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-05-04 | 3,900,212 | 9,164,837 | 13,065,049 | 67.6% |
| 2026-04-27 | 2,231,538 | 951,553 | 3,183,091 | 42.6% |
| 2026-04-20 | 2,600,271 | 2,253,062 | 4,853,333 | 63.3% |
| 2026-04-13 | 6,399,276 | 7,098,814 | 13,498,090 | 48.5% |
| 2026-04-06 | 3,141,928 | 2,236,930 | 5,378,858 | 55.0% |
| 2026-03-30 | 1,523,337 | 867,476 | 2,390,813 | 46.1% |
| 2026-03-23 | 1,025,835 | 1,575,615 | 2,601,450 | 46.3% |
| 2026-03-16 | 1,399,654 | 1,068,558 | 2,468,212 | 38.8% |
| 2026-03-09 | 1,315,356 | 480,112 | 1,795,468 | 37.2% |
| 2026-03-02 | 1,702,925 | 2,412,585 | 4,115,510 | 52.0% |
| 2026-02-23 | 1,966,275 | 1,299,908 | 3,266,183 | 47.9% |
| 2026-02-16 | 1,951,872 | 759,022 | 2,710,894 | 36.7% |
| 2026-02-09 | 2,168,095 | 551,677 | 2,719,772 | 41.7% |
| 2026-02-02 | 2,088,428 | 1,364,445 | 3,452,873 | 44.3% |
| 2026-01-26 | 1,956,192 | 1,735,639 | 3,691,831 | 46.6% |
| 2026-01-19 | 1,672,940 | 1,297,602 | 2,970,542 | 43.8% |
| 2026-01-12 | 8,657,266 | 6,537,321 | 15,194,587 | 45.6% |
| 2026-01-05 | 3,274,238 | 2,645,150 | 5,919,388 | 45.8% |
| 2025-12-29 | 1,490,190 | 736,119 | 2,226,309 | 40.4% |
| 2025-12-22 | 2,556,059 | 1,259,056 | 3,815,115 | 47.2% |
| 2025-12-15 | 2,384,494 | 1,968,682 | 4,353,176 | 38.1% |
Showing 1–21 of 21 weeks